Splice donor site sgRNAs enhance CRISPR/Cas9-mediated knockout efficiency

Area of Science:

• Molecular Biology
• Gene Editing Technologies
• Cancer Research

Background:

• CRISPR/Cas9 induces double-stranded breaks (DSBs) for gene knockout.
• Non-homologous end joining repair can lead to non-null alleles, limiting therapeutic efficacy.
• Ineffective knockout of oncogenes hinders gene therapy.

Purpose of the Study:

• To enhance the efficiency of CRISPR/Cas9 gene knockout.
• To investigate strategies for achieving a true null allele.
• To improve loss-of-function yields in gene therapy.

Main Methods:

• Utilizing CRISPR/Cas9 gene editing technology.
• Designing single-guide RNA (sgRNA) to target splice donor sites (SDS) of critical exons.
• Analyzing the impact of sgRNA targeting SDS on gene splicing and frameshift mutations.

Main Results:

• Targeting the splice donor site (SDS) with sgRNA increases knockout efficiency.
• This strategy enhances the probability of frameshift mutations.
• It also increases the likelihood of interrupting pre-mRNA splicing, leading to null alleles.

Conclusions:

• Targeting splice donor sites is a superior strategy for generating null alleles using CRISPR/Cas9.
• This method improves the yield of loss-of-function mutations.
• Optimizing sgRNA design for SDS targeting is crucial for effective gene therapy.